Reaction Details |
| Report a problem with these data |
Target | Urokinase-type plasminogen activator |
---|
Ligand | BDBM50307296 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_610622 (CHEMBL1069636) |
---|
Ki | 85±n/a nM |
---|
Citation | Wang, S; Beck, R; Burd, A; Blench, T; Marlin, F; Ayele, T; Buxton, S; Dagostin, C; Malic, M; Joshi, R; Barry, J; Sajad, M; Cheung, C; Shaikh, S; Chahwala, S; Chander, C; Baumgartner, C; Holthoff, HP; Murray, E; Blackney, M; Giddings, A Structure based drug design: development of potent and selective factor IXa (FIXa) inhibitors. J Med Chem53:1473-82 (2010) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Urokinase-type plasminogen activator |
---|
Name: | Urokinase-type plasminogen activator |
Synonyms: | 3.4.21.73 | PLAU | U-plasminogen activator | UROK_HUMAN | Urokinase | Urokinase-type plasminogen activator (uPA) | Urokinase-type plasminogen activator chain B | Urokinase-type plasminogen activator long chain A | Urokinase-type plasminogen activator short chain A | Urokinase-type plasminogen activator/surface receptor | uPA |
Type: | Enzyme |
Mol. Mass.: | 48528.62 |
Organism: | Homo sapiens (Human) |
Description: | P00749 |
Residue: | 431 |
Sequence: | MRALLARLLLCVLVVSDSKGSNELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQ
HCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHN
YCRNPDNRRRPWCYVQVGLKLLVQECMVHDCADGKKPSSPPEELKFQCGQKTLRPRFKII
GGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLG
RSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICL
PSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKML
CAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR
SHTKEENGLAL
|
|
|
BDBM50307296 |
---|
n/a |
---|
Name | BDBM50307296 |
Synonyms: | CHEMBL597370 | [2-(2-Carbamimidoyl-benzo[b]thiophen-4-yloxy)-2-phenyl-ethyl]-carbamic acid phenyl ester |
Type | Small organic molecule |
Emp. Form. | C24H21N3O3S |
Mol. Mass. | 431.507 |
SMILES | NC(=N)c1cc2c(OC(CNC(=O)Oc3ccccc3)c3ccccc3)cccc2s1 |
Structure |
|